Humane Genomics

Humane Genomics YC Başvurusu

Summer 2021Active

Humane Genomics, Healthcare şirketi olarak Summer 2021 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.

YC grubu
Summer 2021
Sektör
HealthcareTherapeutics
Ekip büyüklüğü
5
Durum
Active
Lansmanı Yapıldı
2021

Kurucular

  • Peter Weijmarshausen
    Peter WeijmarshausenFounder
  • Chad Moles
    Chad MolesFounder

Humane Genomics ne yapar

Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.

Humane Genomics'in YC başvurusu, yeniden yapılandırılmış

Y Combinator başvurusu

Humane Genomics, Summer 2021 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.

  1. Founders2
  2. Company7
  3. Progress7
  4. Idea4
  5. Equity3
  6. Curious2
  7. Batch Preference1

Company

Company name

Humane Genomics

Describe what your company does in 50 characters or less.

Platform to make artificial viruses for cancer

What is your company going to make? Please describe your product and what it does or will do.

We have built a platform that designs and produces oncolytic RNA viruses that selectively kill cancer cells. Our virus uses two independent targeting mechanisms - selective infection and selective replication - to keep healthy cells safe while attacking tumors. Right now, we're applying this tech to pediatric liver cancer and working with Texas Children's Hospital to validate safety and efficacy in animal models.

Where do you live now, and where would the company be based after YC?

We live in New York, NY, and plan to base the company there after YC as well.

Explain your decision regarding location.

We are based in New York because that's where our team is and where we've built our lab and partnerships. It makes sense to stay where we have existing infrastructure and clinical collaborators.

Tam başvuruda 21 ek cevap

Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.

Sıkça Sorulan Sorular

Bu, Humane Genomics şirketinin gerçek YC başvurusu mu?

Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Humane Genomics'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Humane Genomics gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.

Humane Genomics hangi YC grubundaydı?

Humane Genomics, Y Combinator Summer 2021 grubundaydı.

Humane Genomics kim tarafından kuruldu?

Humane Genomics, Peter Weijmarshausen, Chad Moles tarafından kuruldu.

Humane Genomics ne iş yapar?

A platform to make artificial viruses as cancer therapeutics.

Tam yeniden oluşturulmuş başvuruyu nasıl okurum?

Ücretsiz bir Round Funded hesabı oluşturun. Humane Genomics'ın başvurusunun tam 26 soruluk versiyonu ve diğer tüm YC batch'leri YC Insights'ta.

Humane Genomics gibi daha fazla YC girişimi